These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2538422)

  • 1. The binding of a K+ competitive ligand, 2-methyl,8-(phenylmethoxy)imidazo(1,2-a)pyridine 3-acetonitrile, to the gastric (H+ + K+)-ATPase.
    Keeling DJ; Taylor AG; Schudt C
    J Biol Chem; 1989 Apr; 264(10):5545-51. PubMed ID: 2538422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of a K(+)-competitive inhibitor, a substituted imidazo[1,2a] pyridine, with the phospho- and dephosphoenzyme forms of H+, K(+)-ATPase.
    Mendlein J; Sachs G
    J Biol Chem; 1990 Mar; 265(9):5030-6. PubMed ID: 2156860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Laing SM; Senn-Bilfinger J
    Biochem Pharmacol; 1988 Jun; 37(11):2231-6. PubMed ID: 2837231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of H+,K+-ATPase by a K+-competitive photoaffinity inhibitor.
    Munson KB; Sachs G
    Biochemistry; 1988 May; 27(11):3932-8. PubMed ID: 2843221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of H+/K(+)-ATPase by inorganic phosphate. The role of K+ and SCH 28080.
    Van der Hijden HT; Koster HP; Swarts HG; De Pont JJ
    Biochim Biophys Acta; 1991 Jan; 1061(2):141-8. PubMed ID: 1847826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCH 28080 is a more selective inhibitor than SCH 32651 at the K+ site of gastric K+/H+-ATPase.
    Beil W; Staar U; Sewing KF
    Eur J Pharmacol; 1987 Jul; 139(3):349-52. PubMed ID: 2822435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.
    Wallmark B; Briving C; Fryklund J; Munson K; Jackson R; Mendlein J; Rabon E; Sachs G
    J Biol Chem; 1987 Feb; 262(5):2077-84. PubMed ID: 3029064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cl- channel in hog gastric vesicles is part of the function of H,K-ATPase.
    Asano S; Inoie M; Takeguchi N
    J Biol Chem; 1987 Sep; 262(27):13263-8. PubMed ID: 2443490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Malcolm RC; Laing SM; Ife RJ; Leach CA
    Biochem Pharmacol; 1991 Jun; 42(1):123-30. PubMed ID: 1648919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
    Kaminski JJ; Wallmark B; Briving C; Andersson BM
    J Med Chem; 1991 Feb; 34(2):533-41. PubMed ID: 1847427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of putative SCH 28080 binding sites of the gastric H+,K+-ATPase.
    Asano S; Matsuda S; Tega Y; Shimizu K; Sakamoto S; Takeguchi N
    J Biol Chem; 1997 Jul; 272(28):17668-74. PubMed ID: 9211917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformation-dependent inhibition of gastric H+,K+-ATPase by SCH 28080 demonstrated by mutagenesis of glutamic acid 820.
    Swarts HG; Hermsen HP; Koenderink JB; Willems PH; de Pont JJ
    Mol Pharmacol; 1999 Mar; 55(3):541-7. PubMed ID: 10051539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutaraldehyde crosslinking analysis of the C12E8 solubilized H,K-ATPase.
    Rabon EC; Bassilian S; Jakobsen LJ
    Biochim Biophys Acta; 1990 Jul; 1039(3):277-89. PubMed ID: 2165816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080.
    Scott CK; Sundell E; Castrovilly L
    Biochem Pharmacol; 1987 Jan; 36(1):97-104. PubMed ID: 3026407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity labeling of the lumenal K+ site of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Fallowfield C; Lawrie KM; Saunders D; Richardson S; Ife RJ
    J Biol Chem; 1989 Apr; 264(10):5552-8. PubMed ID: 2925619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of H+K+ATPase by SCH 28080 and SCH 32651.
    Scott CK; Sundell E
    Eur J Pharmacol; 1985 Jun; 112(2):268-70. PubMed ID: 2993001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phospholipid flippase activity of gastric vesicles.
    Suzuki H; Kamakura M; Morii M; Takeguchi N
    J Biol Chem; 1997 Apr; 272(16):10429-34. PubMed ID: 9099684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.
    Briving C; Andersson BM; Nordberg P; Wallmark B
    Biochim Biophys Acta; 1988 Dec; 946(2):185-92. PubMed ID: 2850003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of SCH 28080 with the gastric (H+ +K+)-ATPase.
    Keeling DJ; Laing SM; Senn-Bilfinger J
    Prog Clin Biol Res; 1988; 273():255-60. PubMed ID: 2843918
    [No Abstract]   [Full Text] [Related]  

  • 20. The substitution of calcium for magnesium in H+,K+-ATPase catalytic cycle. Evidence for two actions of divalent cations.
    Mendlein J; Sachs G
    J Biol Chem; 1989 Nov; 264(31):18512-9. PubMed ID: 2553712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.